SCHEMBL5680640

SCHEMBL5680640

CCc1cc(C)cc(O)c1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SELL P14151 1/20 0.59
SELP P16109 1/20 0.59
SELE P16581 1/20 0.59
ALDH1A1 P00352 4/20 0.50
HTT P42858 3/20 0.50
GAA P10253 2/20 0.50
HPGD P15428 1/20 0.50
MAPK1 P28482 1/20 0.50
PPARG P37231 1/20 0.50
MAPK10 P53779 1/20 0.50
NCOA2 Q15596 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
ACHE P22303 1/20 0.46
AMY1A P0DUB6 1/20 0.45
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
APEX1 P27695 1/20 0.43
MPI P34949 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27752703 0.88 SELL (0.46) SELLSELPSELEALDH1A1HTT
SCHEMBL45859 0.87 GABRA1 (0.52) SELLSELPSELEALDH1A1HTT
SCHEMBL18904543 0.87 ALDH1A1 (0.45) SELLSELPSELEALDH1A1HTT
SCHEMBL8912144 0.83 AMY1A (0.63) SELLSELPSELEALDH1A1HTT
SCHEMBL5676839 0.82 SELL (0.54) SELLSELPSELEALDH1A1HTT
SCHEMBL14612685 0.82 SELL (0.42) SELLSELPSELEALDH1A1HTT
SCHEMBL23339864 0.81 AMY1A (0.67) SELLSELPSELEALDH1A1HTT
SCHEMBL30576381 0.81 ALDH1A1 (0.48) SELLSELPSELEALDH1A1HTT
SCHEMBL1021767 0.81 ALDH1A1 (0.48) SELLSELPSELEALDH1A1HTT
SCHEMBL31530705 0.81 SELL (0.59) SELLSELPSELEALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170153547-A1 COATING COMPOSITIONS FOR USE WITH AN OVERCOATED PHOTORESIST DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-06-01 US disclosed
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 US disclosed
EP-1620447-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III Exxonmobil Chemical Patents Inc. (US) 2006-02-01 EP disclosed
WO-2003102006-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR SELL 1902/4885SELP 1617/4885SELE 255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.